| 000 | 02506 a2200637 4500 | ||
|---|---|---|---|
| 005 | 20250514183541.0 | ||
| 264 | 0 | _c20041021 | |
| 008 | 200410s 0 0 eng d | ||
| 022 | _a1346-9843 | ||
| 024 | 7 |
_a10.1253/circj.68.280 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatanabe, Kazuhiro | |
| 245 | 0 | 0 |
_aRelationship between the door-to-TIMI-3 flow time and the infarct size in patients suffering from acute myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial. _h[electronic resource] |
| 260 |
_bCirculation journal : official journal of the Japanese Circulation Society _cApr 2004 |
||
| 300 |
_a280-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aCoronary Circulation |
| 650 | 0 | 4 |
_aCreatine Kinase _xblood |
| 650 | 0 | 4 | _aCreatine Kinase, MB Form |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 |
_aEmergency Service, Hospital _xstatistics & numerical data |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFibrinolysis |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 |
_aHospitals, University _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xblood |
| 650 | 0 | 4 |
_aJapan _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xblood |
| 650 | 0 | 4 |
_aMyocardial Reperfusion _xmethods |
| 650 | 0 | 4 |
_aPatient Admission _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPlasminogen Activators _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aStroke Volume |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xstatistics & numerical data |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTroponin T _xblood |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xadministration & dosage |
| 700 | 1 | _aNagao, Ken | |
| 700 | 1 | _aWatanabe, Ikuyoshi | |
| 700 | 1 | _aKanmatsuse, Katsuo | |
| 773 | 0 |
_tCirculation journal : official journal of the Japanese Circulation Society _gvol. 68 _gno. 4 _gp. 280-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1253/circj.68.280 _zAvailable from publisher's website |
| 999 |
_c14773092 _d14773092 |
||